Top

Reactions Weekly

Published in:

01-06-2012 | Case report

Sulprostone

Hyperthermia and neurological disorders: case report

Published in: Reactions Weekly | Issue 1/2012

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:

death
life-threatening
hospitalisation
disability
congenital anomaly
requires intervention to prevent permanent impairment or damage

…

Cellier Q, Gamerre L, Cortey C, Clement H-J, Viale J-P.Severe hyperthermia and neurological disorders following prostaglandin treatment for uterine atonia after caesarean section. Annales Francaises d'Anesthesie et de Reanimation 31: 243-245, No. 3, Mar 2012. Available from: URL: http://dx.doi.org/10.1016/j.annfar.2012.01.001 - France

Title: Sulprostone
Hyperthermia and neurological disorders: case report
Publication date: 01-06-2012
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2012
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.2165/00128415-201214060-00120

At a glance: The STEP trials

Springer Medicine

Sulprostone

Hyperthermia and neurological disorders: case report

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2012

Metformin

Cangene recalls Hep B immune globulin due to thrombosis risk

Ezetimibe may lead to paradoxical progression of atherosclerosis

Interferon

Daptomycin/linezolid/vancomycin

Thiamazole